Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuneaki Hirakawa

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Clinical and Experimental Hematopathology : JCEH|June 2, 2011
Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphomaHiroki Yamaguchi, Tsuneaki Hirakawa, Koiti Inokuchi
Annals of Hematology|April 24, 2010
Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphomaTsuneaki Hirakawa, Hiroki Yamaguchi, Norio Yokose, et al.
International Journal of Hematology|August 25, 2011
RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocationsKoiti Inokuchi, Satoshi Wakita, Tsuneaki Hirakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[Haploidentical stem cell transplantation for acute myeloid leukemia associated with adult-onset Shwachman-Diamond syndrome]Yu Uemura, Tsuneaki Hirakawa, Manabu Matsunawa, et al.
International Journal of Hematology|September 12, 2023
Leukemic-phase mucosa-associated lymphoid tissue lymphomaTakayuki Yotsuyanagi, Naoto Tomita, Yusuke Saiki, et al.
Hematological Oncology|March 17, 2026
Valemetostat Therapy for Relapsed Adult T-Cell Leukemia/Lymphoma After Allogeneic Hematopoietic Stem Cell TransplantationShota Furukawa, Ayumu Ito, Mamoru Nagata, et al.
International Journal of Hematology|January 30, 2021
Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomographyYusuke Saiki, Naoto Tomita, Akiko Uchida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Japan Marrow Donor Program and its coordinating process: current situations]Tsuneaki Hirakawa, Saiko Kurosawa, Kinuko Tajima, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|April 3, 2020
Presence of Promyelocytes in Peripheral Blood as a Novel Predictor of Optimal Timing for Single-Step Peripheral Blood Stem Cell CollectionAtsushi Marumo, Hiroki Yamaguchi, Tsuneaki Hirakawa, et al.
Transplantation and Cellular Therapy|July 1, 2026
Real-world use of maribavir for refractory CMV infection and intolerance to conventional anti-CMV agents after allogeneic hematopoietic cell transplantationRisa Nishiyama, Ayumu Ito, Yu Akahoshi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Clinical and Experimental Hematopathology : JCEH|June 2, 2011
Importance of relative dose intensity in chemotherapy for diffuse large B-cell lymphomaHiroki Yamaguchi, Tsuneaki Hirakawa, Koiti Inokuchi
Annals of Hematology|April 24, 2010
Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphomaTsuneaki Hirakawa, Hiroki Yamaguchi, Norio Yokose, et al.
International Journal of Hematology|August 25, 2011
RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocationsKoiti Inokuchi, Satoshi Wakita, Tsuneaki Hirakawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 10, 2022
[Haploidentical stem cell transplantation for acute myeloid leukemia associated with adult-onset Shwachman-Diamond syndrome]Yu Uemura, Tsuneaki Hirakawa, Manabu Matsunawa, et al.
International Journal of Hematology|September 12, 2023
Leukemic-phase mucosa-associated lymphoid tissue lymphomaTakayuki Yotsuyanagi, Naoto Tomita, Yusuke Saiki, et al.
Hematological Oncology|March 17, 2026
Valemetostat Therapy for Relapsed Adult T-Cell Leukemia/Lymphoma After Allogeneic Hematopoietic Stem Cell TransplantationShota Furukawa, Ayumu Ito, Mamoru Nagata, et al.
International Journal of Hematology|January 30, 2021
Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomographyYusuke Saiki, Naoto Tomita, Akiko Uchida, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 9, 2018
[Japan Marrow Donor Program and its coordinating process: current situations]Tsuneaki Hirakawa, Saiko Kurosawa, Kinuko Tajima, et al.
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|April 3, 2020
Presence of Promyelocytes in Peripheral Blood as a Novel Predictor of Optimal Timing for Single-Step Peripheral Blood Stem Cell CollectionAtsushi Marumo, Hiroki Yamaguchi, Tsuneaki Hirakawa, et al.
Transplantation and Cellular Therapy|July 1, 2026
Real-world use of maribavir for refractory CMV infection and intolerance to conventional anti-CMV agents after allogeneic hematopoietic cell transplantationRisa Nishiyama, Ayumu Ito, Yu Akahoshi, et al.
Pageof 3